Claude Gimmi

2.2k total citations
30 papers, 1.9k citations indexed

About

Claude Gimmi is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Claude Gimmi has authored 30 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Immunology and 9 papers in Oncology. Recurrent topics in Claude Gimmi's work include Immunotherapy and Immune Responses (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and T-cell and B-cell Immunology (6 papers). Claude Gimmi is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and T-cell and B-cell Immunology (6 papers). Claude Gimmi collaborates with scholars based in United States, Switzerland and Germany. Claude Gimmi's co-authors include Lee M. Nadler, G S Gray, John G. Gribben, Gordon J. Freeman, G J Freeman, K Sugita, Chikao Morimoto, AS Freedman, JG Gribben and David B. Lombard and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Claude Gimmi

30 papers receiving 1.8k citations

Peers

Countries citing papers authored by Claude Gimmi

Since Specialization

Citations

This map shows the geographic impact of Claude Gimmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude Gimmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude Gimmi more than expected).

Fields of papers citing papers by Claude Gimmi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claude Gimmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude Gimmi. The network helps show where Claude Gimmi may publish in the future.

Co-authorship network of co-authors of Claude Gimmi

This figure shows the co-authorship network connecting the top 25 collaborators of Claude Gimmi. A scholar is included among the top collaborators of Claude Gimmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claude Gimmi. Claude Gimmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A First-in-human, Dose-escalation Study of the Methionine Aminopeptidase 2 Inhibitor M8891 in Patients with Advanced Solid Tumors 2023 ·Cancer Research Communications ·Michael A. Carducci, Ding Wang, (unknown), Matthias Bödding, Felix Rohdich, (unknown), (unknown), Oleksandr Karpenko, (unknown), Claude Gimmi, Patricia LoRusso	5
2	Translational PK/PD Modeling of Tumor Growth Inhibition and Target Inhibition to Support Dose Range Selection of the LMP7 Inhibitor M3258 in Relapsed/Refractory Multiple Myeloma 2022 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), Christina Esdar, (unknown), Manja Friese‐Hamim, Sofia Stinchi, Elise E. Drouin, Samer El Bawab, (unknown), Claude Gimmi, Michael P. Sanderson, Felix Rohdich	5
3	566P A multicenter, open-label, dose-escalation, first-in-man study of MetAP2 inhibitor M8891 in patients with advanced solid tumours 2020 ·Annals of Oncology ·Michael A. Carducci, Ding Wang, (unknown), (unknown), Felix Rohdich, Sofia Stinchi, (unknown), Claude Gimmi, Patricia LoRusso	1
4	Abstract CT011: First-in-human Phase I study of M4112, the first dual inhibitor of indoleamine 2,3-dioxygenase-1 and tryptophan 2,3-dioxygenase 2, in patients with advanced solid malignancies 2019 ·Cancer Research ·Kyriakos P. Papadopoulos, Paul S. Eder, Sarina A. Piha‐Paul, Claude Gimmi, Elizabeth K. Hussey, Sen Zhang, Lu Li, (unknown), Aung Naing	3
5	Abstract CT011: First-in-human Phase I study of M4112, the first dual inhibitor of indoleamine 2,3-dioxygenase-1 and tryptophan 2,3-dioxygenase 2, in patients with advanced solid malignancies 2019 ·Clinical Trials ·(unknown), (unknown), Sarina A. Piha‐Paul, Claude Gimmi, Elizabeth K. Hussey, Sen Zhang, Lu Li, Christina Habermehl, Aung Naing	1
6	Differential Effect on Bone Lesions of Targeting Integrins: Randomized Phase II Trial of Abituzumab in Patients with Metastatic Castration-Resistant Prostate Cancer 2016 ·Clinical Cancer Research ·Maha Hussain, Sylvestre Le Moulec, Claude Gimmi, Rolf Bruns, Josef Straub, Kurt Miller	48
7	The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of CH4987655 in Healthy Volunteers: Target Suppression Using a Biomarker 2009 ·Clinical Cancer Research ·(unknown), Huifeng Niu, Ruediger Rueger, (unknown), Jonathan Deutsch, Nobuya Ishii, Song Mu, (unknown), (unknown), Claude Gimmi, Petra Goelzer, Stefanie De Schepper, (unknown), Joanne Barrett, Yuji Ishikawa, Georges Weissgerber, Richard Peck	30
8	Current Stumbling Blocks in Oncology Drug Development 2007 ·PubMed ·Claude Gimmi	1
9	Virosomes as new carrier system for cancer vaccines 2004 ·Cancer Immunology Immunotherapy ·Ruth Schwaninger, Ernst R. Waelti, Paul Zajac, Antoinette Wetterwald, (unknown), Claude Gimmi	17
10	Targeting her-2/neu with antirat Neu virosomes for cancer therapy. 2002 ·PubMed ·Ernst R. Waelti, (unknown), Ruth Schwaninger, (unknown), (unknown), Barbara Rothen‐Rutishauser, Claude Gimmi	49
11	Role of Fas ligand expression in promoting escape from immune rejection in a spontaneous tumor model 2001 ·International Journal of Cancer ·(unknown), (unknown), (unknown), Andreas Marti, Rolf Jaggi, Claude Gimmi	19
12	Functional characterization of Fas ligand on tumor cells escaping active specific immunotherapy 2001 ·Cell Death and Differentiation ·Daniel Céfaï, Ruth Schwaninger, (unknown), Thomas Brunner, Claude Gimmi	13
13	Over-expression of erbB-2/neu is paralleled by inhibition of mouse-mammary-epithelial-cell differentiation and developmental apoptosis 2000 ·International Journal of Cancer ·Hedvika Lazar, (unknown), Claude Gimmi, (unknown), Rolf Jaggi	1
14	Over-expression of erbB-2/neu is paralleled by inhibition of mouse-mammary-epithelial-cell differentiation and developmental apoptosis 2000 ·International Journal of Cancer ·Hedvika Lazar, Anna Baltzer, Claude Gimmi, Andreas Marti, Rolf Jaggi	14
15	Targeting HER-2/neu for active-specific immunotherapy in a mouse model of spontaneous breast cancer 1999 ·International Journal of Cancer ·(unknown), Briggs Morrison, Axel Sckell, (unknown), (unknown), Michael Leunig, Claude Gimmi	45
16	Breast cancer–associated antigen, DF3/MUC1, induces apoptosis of activated human T cells 1996 ·Nature Medicine ·Claude Gimmi, Briggs Morrison, B. Mainprice, John G. Gribben, Vassiliki A. Boussiotis, Gordon J. Freeman, (unknown), Michiaki Watanabe, Jianlin Gong, Daniel F. Hayes, Donald Küfe, Lee M. Nadler	142
17	CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production 1992 ·The Journal of Immunology ·Gordon J. Freeman, David B. Lombard, Claude Gimmi, Staley A. Brod, (unknown), Joseph Laning, D A Hafler, Martin E. Dorf, G S Gray, Hans Reiser	132
18	Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. 1991 ·The Journal of Experimental Medicine ·Gordon J. Freeman, G S Gray, Claude Gimmi, David B. Lombard, Libo Zhou, Morris F. White, Joyce D. Fingeroth, John G. Gribben, Lee M. Nadler	299
19	Dexamethasone and 1,25-dihydroxyvitamin D3, but not cyclosporine A, inhibit production of granulocyte-macrophage colony-stimulating factor in human fibroblasts 1991 ·Blood ·A Tobler, (unknown), Claude Gimmi, (unknown), Susanne Saurer, MF Fey	13
20	B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. 1991 ·Proceedings of the National Academy of Sciences ·Claude Gimmi, Gordon J. Freeman, JG Gribben, K Sugita, AS Freedman, Chikao Morimoto, Lee M. Nadler	394

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact